Back to MORGAN STANLEY MORGAN STANLEY

CRDLCRDL
Showing 8 of 9 quarters

Position history for MORGAN STANLEYMORGAN STANLEY's holdings in CARDIOL THERAPEUTICS INC

MORGAN STANLEY holds 355,030 shares of CRDL (CARDIOL THERAPEUTICS INC), worth $376,332 as of 2026-Q2. The position was increased (+41.8% shares).

Current Value

$376,332

Current Shares

355,030

Total Value Change

+$250,206

Total Shares Change

+291,330

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
355,030
+41.8%
$376,3320.0%$1.06
22
2026-Q1
Decreased
250,421
-27.3%
$338,0680.0%$1.01
0
2025-Q4
Increased
344,463
+120.3%
$328,5490.0%$0.97
26
2025-Q3
Increased
156,331
+56.5%
$167,2740.0%$1.14
22
2025-Q2
Increased
99,881
+67.5%
$135,8380.0%$1.41
22
2025-Q1
Decreased
59,613
-70.9%
$57,8130.0%$0.96
0
2024-Q4
Increased
204,543
+221.1%
$261,8160.0%$1.28
25
2024-Q3
Increased
63,700
+133.3%
$126,1260.0%$2.07
24

Other major holders of CRDL: Mirae Asset Global Investments Co., Ltd., CITADEL ADVISORS LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used